PSG’s PBM Customer Satisfaction Report provides the most in-depth picture of the PBM landscape today, leveraging perspectives taken directly from employer and health plan…
Choosing, negotiating a contract, and navigating a relationship with a pharmacy benefit manager (PBM) isn’t one size fits all. No single PBM is “best”…
Customer Satisfaction Report Dives into Current PBM Sentiment by Plan Sponsors DALLAS, TX – Pharmaceutical Strategies Group (PSG), an EPIC company, has released its…
Much has been written about the sweeping changes contained in the Inflation Reduction Act of 2022 (IRA), including provisions that affect drug pricing. I’ve…
Get the Full Analysis of the Big 3 Formulary Changes: 2023 Formulary Changes: CVS Health 2023 Formulary Changes: Express Scripts 2023 Formulary Changes: OptumRx…
Migraines represent the world’s third most prevalent illness. A new class of drugs called calcitonin gene-related peptide (CGRP) inhibitors entered the market in 2018.
Dallas, TX and San Francisco, CA (August 29, 2022) Pharmaceutical Strategies Group (PSG), an EPIC company, announced an enhancement of its data and analytics platform,…
